1. Ahmad A, Hanby A, Dublin E, Poulsom R, Smith P, Barnes D, Rubens R, Anglard P, Hart I. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol 1998; 152: 721–728.
2. Ahmad A, Marshall JF, Basset P, Anglard P, Hart, IR. Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells. Int J Cancer 1997; 73: 290–296.
3. Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DG, Richards WG, Sunday M, Kobzik L, Shipp MA. Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res 1995; 55: 4120–4126.
4. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478–1487.
5. Barbacid MM, Fernandez-Resa P, Buesa JM, Marquez G, Aracil M, Mira E. Expression and purification of human stromelysin 1 and 3 from baculovirus-infected insect cells. Protein Expr Purif 1998; 13: 243–250.